| name: | Esflurbiprofen | |
| ATC code: | M02AA29 | route: | topical | 
| compartments: | 1 | |
| dosage: | 50 | mg | 
| volume of distribution: | 10 | L | 
| clearance: | 1 | L/h | 
| other parameters in model implementation | ||
Esflurbiprofen is the S-enantiomer of flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID) that exhibits analgesic and anti-inflammatory properties primarily through inhibition of cyclooxygenase (COX) enzymes. Esflurbiprofen has been investigated as a topical agent for musculoskeletal and joint pain, but it is not widely approved as a separate medication in most countries, with its parent racemate (flurbiprofen) being used more commonly.
Pharmacokinetic parameters are not directly available in peer-reviewed literature for esflurbiprofen itself. Estimates below are inferred based on typical topical NSAID characteristics and existing flurbiprofen data.